PEPTIDE_CODEX

← All peptides

PC-016 · growth-hormone · hexarelin

Hexarelin

Examorelin

Also: HEX

human trialanimal study

A synthetic hexapeptide GH secretagogue with the strongest initial GH release of any GHRP. However, Hexarelin is notable for significant desensitisation — the GH response diminishes with continuous use. It also has unique cardioprotective properties independent of GH release.

Strong ghrelin receptor (GHSR) agonist producing powerful GH pulses. Additionally activates cardiac receptors (CD36) providing cardioprotective effects independent of GH. Receptor desensitisation occurs after 4-8 weeks of continuous use.

  • GH release (short-term)
  • Cardioprotection
  • Fat loss
  • Muscle growth
  • · Cortisol/prolactin elevation
  • · Water retention
  • · Receptor desensitisation
  • · Hunger

Mechanism of Action

Strong ghrelin receptor (GHSR) agonist producing powerful GH pulses. Additionally activates cardiac receptors (CD36) providing cardioprotective effects independent of GH. Receptor desensitisation occurs after 4-8 weeks of continuous use.

Common Uses

GH release (short-term)CardioprotectionFat lossMuscle growth

Dosage & Pharmacology

DOSAGE RANGE: 100-200 mcg 2-3x daily (subcutaneous), cycled 4-8 weeks
HALF-LIFE: ~70 minutes
MOL. WEIGHT: 887.04 Da
Dosage information is for research reference only. Not a recommendation.

Known Side Effects

  • Cortisol/prolactin elevation
  • Water retention
  • Receptor desensitisation
  • Hunger

Legal Status

US:Not FDA-approved, research chemical
UK:Not approved
EU:Not approved
AU:Not approved
View all Hexarelin research on PubMed